Approximately 50%-60% of HER2-positive breast cancer are classified as HER2-E, with the remaining half distributed among luminal A (15%-20%), luminal B (10%-15%), and basal-like (5%-10%)[37]. This evidence concerns the gene ERBB2 and breast carcinoma.